CORDiguide

Company Overview

Snapshot

Founded in January 2021 by Rafael Beyar and Yehoshua (Josh) Zeevi, CORDiguide operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-based technology for medical interventions. In March 2021, CORDiguide was announced as a medical spin-off of Cortica, leveraging autonomous AI technology.

Business overview

CORDiguide develops AI-based technology for the real-time guidance and navigation of catheters during cardiological and cerebral interventional procedures, which are performed under angiographic imaging. The company's systems utilize artificial intelligence to localize the treatment of cancerous tissues by guiding miniature devices, such as stents, along blood vessels to their target. CORDiguide operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, serving healthcare providers in hospitals.

Strategic signal

In March 2021, CORDiguide was announced as a medical spin-off from Cortica, indicating a strategic move to apply advanced autonomous AI technology to the medical field. This development signals a focused effort to innovate catheter guidance in interventional cardiology and neurology, potentially enhancing precision and outcomes in complex procedures and validating the commercial potential of Cortica's AI in a new vertical.

Company Intelligence Q&A

When was CORDiguide founded?

CORDiguide was founded in January 2021.

Who are the founders of CORDiguide?

CORDiguide was co-founded by Rafael Beyar and Yehoshua (Josh) Zeevi.

What is CORDiguide's primary focus?

CORDiguide focuses on developing AI-based technology for real-time guidance and navigation of catheters in cardiological and cerebral interventional procedures.

What significant corporate development occurred in March 2021?

In March 2021, Cortica announced CORDiguide as a medical spin-off, leveraging its autonomous AI technology for medical applications.

What technology does CORDiguide utilize?

CORDiguide utilizes artificial intelligence to localize treatment and guide miniature devices like stents along blood vessels to target areas.